West Pharmaceutical Services | WST - Cash And Equivalent


West Pharmaceutical Services reported $521.4M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Align Technology USD 1.06B 35.07M Mar/2026
Avanos Medical USD 65.6M 24.2M Mar/2026
Baxter International USD 2.02B 51M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Cerus USD 19.96M 4.29M Dec/2025
Charles River Laboratories USD 191.83M 21.94M Mar/2026
Cooper Companies USD 124.9M 14.3M Dec/2025
Dentsply International USD 190M 136M Mar/2026
Haemonetics USD 245.44M 117.93M Mar/2026
ICU Medical USD 307.96M 8.23M Dec/2025
Insulet USD 480.4M 235.7M Mar/2026
Integra LifeSciences USD 236.81M 1.76M Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Merit Medical Systems USD 488.08M 41.68M Mar/2026
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 176.96M 22.31M Mar/2026
Quidel USD 140.4M 29.4M Mar/2026
Repligen USD 582.65M 16.63M Mar/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
Solventum Corp USD 561M 317M Mar/2026
STAAR Surgical USD 153.15M 23M Dec/2025
Terumo JPY 217.16B 12.86B Sep/2025
Utah Medical Products USD 84.27M 2.09M Sep/2025
West Pharmaceutical Services USD 521.4M 269.9M Mar/2026